Quantumscape Corp vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Quantumscape Corp trades at $3.89 (market cap $2.55B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 4.2× Quantumscape Corp's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quantumscape Corp for 37 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| QS | RDY | |
|---|---|---|
Market Cap | $2.55B | $10.78B |
Volume | 12,145,789 | 2,724,343 |
Sector | Consumer Cyclical | Health |
52-Week High | $18.44 | $15.38 |
52-Week Low | $3.93 | $11.38 |
Typical Hold Time | 37 Days | 0 Days |
Enterprise Value | $1.76B | $10.68B |
Dividend Yield | — | 0.65% |
Signals from Pluang's Aura AI — not financial advice
QuantumScape (QS) trades at $3.93, down 7.96% today, reflecting ongoing investor skepticism about its path to commercialization. The company remains pre-revenue with significant losses (-$435.05M net income in 2025) and negative profitability metrics (ROE -39.08%). Technical indicators show a bearish trend with oversold RSI readings, while analyst consensus leans heavily toward Hold (72.73%) with a $10.35 price target suggesting potential upside if execution improves.
QS faces substantial execution risk with commercialization delayed until at least 2029 and intense competition in solid-state batteries. The stock offers high-risk speculative potential for investors betting on breakthrough technology adoption, but requires patience through years of cash burn and dependency on future manufacturing success with partners like Volkswagen.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →